RT Journal Article
SR Electronic
A1 Alexander, Lori
T1 Treating Stage I to III Non-Small-Cell Lung Cancer with Limited Evidence
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 4
SP 32
OP 33
DO 10.1177/155989771304019
UL http://mdc.sagepub.com/content/13/4/32.abstract
AB The treatment of non-small cell lung cancer (NSCLC) presents several challenges. Practice guidelines are based on limited evidence, and are often unclear and subject to multiple interpretations. Determining when mediastinal lymph nodes should be sampled, and how to best treat stage III disease, presents a particular challenge. Better treatment outcomes are needed.